UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000016358 |
|---|---|
| Receipt number | R000018996 |
| Scientific Title | The diagnosis of pleuroperitoneal communication by contrast enhanced ultrasonography with perflubutane |
| Date of disclosure of the study information | 2015/01/28 |
| Last modified on | 2022/02/03 02:15:30 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The diagnosis of pleuroperitoneal communication by contrast enhanced ultrasonography with perflubutane
Acronym
The diagnosis of pleuroperitoneal communication by contrast enhanced ultrasonography with perflubutane
Scientific Title
The diagnosis of pleuroperitoneal communication by contrast enhanced ultrasonography with perflubutane
Scientific Title:Acronym
The diagnosis of pleuroperitoneal communication by contrast enhanced ultrasonography with perflubutane
Region
| Japan |
Condition
Condition
hydrothorax
Classification by specialty
| Hepato-biliary-pancreatic medicine | Chest surgery |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The efficacy of contrast enhanced ultrasonography for the diagnosis of pleuroperitoneal communication
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The assessment of the diagnostic rate of pleuroperitonal communication by contrast enhanced ultrasonography
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
patients with hydrothorax and ascites
Key exclusion criteria
patients with egg allergy
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Masahiko |
| Middle name | |
| Last name | Koda |
Organization
Tottori University, School of Medicine
Division name
Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine,
Zip code
683-8504
Address
Yonago 683-8504, Japan
TEL
0859-38-6527
masakoda89@yahoo.co.jp
Public contact
Name of contact person
| 1st name | Masahiko |
| Middle name | |
| Last name | Koda |
Organization
Tottori University, School of Medicine
Division name
Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine,
Zip code
683-8504
Address
Yonago 683-8504, Japan
TEL
0859-38-6527
Homepage URL
masakoda89@yahoo.co.jp
Sponsor or person
Institute
Tottori University, School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Tottori University, School of Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Tottori University, School of Medicine
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tottori university
Address
Yonago 683-8504, Japan
Tel
0859-38-6527
masakoda89@yahoo.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 01 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2015 | Year | 01 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 01 | Month | 28 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We investiga te the detection rate of pleuroperitoneal communication in patients with hydrothorax.
We investigate the disappearance rate of hydrothorax after the treatment of pleuroperitoneal communication.
Management information
Registered date
| 2015 | Year | 01 | Month | 28 | Day |
Last modified on
| 2022 | Year | 02 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018996
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
